Evidence map›Paper›PMID 12192603›Full record

ArticleNeoplasia (New York, N.Y.)

Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.

Tarek G Gharib, Guoan Chen, Hong Wang, Chiang-Ching Huang, Michael S Prescott, Kerby Shedden, David E Misek, Dafydd G Thomas, Thomas J Giordano, Jeremy M G Taylor and 5 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Neoplasia (New York, N.Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Single-cell western blotting of cytoplasmic cytokeratin 8 proteoforms.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Proteomic biomarkers in lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2013
    Review
  9. miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  10. Article
  11. Lung cancer proteomics: recent advances in biomarker discovery.International journal of proteomics · 2011
    Article
  12. Article
  13. Review
  14. Article
  15. Mass spectrometry-based proteomic profiling of lung cancer.Proceedings of the American Thoracic Society · 2009
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Protein profiles associated with survival in lung adenocarcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 2 countries.

Tarek G GharibDepartment of Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
Guoan Chen
Hong Wang
Chiang-Ching Huang
Michael S Prescott
Kerby Shedden
David E Misek
Dafydd G Thomas
Thomas J Giordano
Jeremy M G Taylor
Sharon Kardia
John Yee
Mark B Orringer
Samir Hanash
David G Beer
University of Michigan–Ann Arbor · US

Funding

Role of ATM in Radiosensitivity of GliomasR01CA085953 · NCI · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI GUHA, CHANDAN · 2002 to 2004
$814k
NCI NIH HHS R01 CA085953NCI NIH HHS U19 CA-85953
6 · The paper itself

Abstract

Cytokeratins (CK) are intermediate filaments whose expression is often altered in epithelial cancer. Systematic identification of lung adenocarcinoma proteins using two-dimensional polyacrylamide gel electrophoresis and mass spectrometry has uncovered numerous CK isoforms. In this study, 93 lung adenocarcinomas (64 stage I and 29 stage III) and 10 uninvolved lung samples were quantitatively examined for protein expression. Fourteen of 21 isoforms of CK 7, 8, 18, and 19 occurred at significantly higher levels (P < .05) in tumors compared to uninvolved adjacent tissue. Specific isoforms of the four types of CK identified correlated with either clinical outcome or individual clinical-pathological parameters. All five of the CK7 isoforms associated with patient survival represented cleavage products. Two of five CK7 isoforms (nos. 2165 and 2091), one of eight CK8 isoforms (no. 439), and one of three CK19 isoforms (no. 1955) were associated with survival and significantly correlated to their mRNA levels, suggesting that transcription underlies overexpression of these CK isoforms. Our data indicate substantial heterogeneity among CK in lung adenocarcinomas resulting from posttranslational modifications, some of which correlated with patient survival and other clinical parameters. Therefore, specific isoforms of individual CK may have utility as diagnostic or predictive markers in lung adenocarcinomas.

Indexed as

AdenocarcinomaAgedBiomarkers, TumorBlotting, WesternElectrophoresis, Gel, Two-DimensionalFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansImmunoenzyme TechniquesKeratinsLung NeoplasmsMaleOligonucleotide Array Sequence AnalysisPrognosisProtein IsoformsBiomarkers, TumorKeratinsProtein IsoformsProteomeRNA, MessengerRNA, Neoplasm

Identifiers

PMID12192603
PMCPMC1661678
OpenAlexW2055115454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.